Enabling access to essential medicines

AA223E52F461C165A873FD105E825289Health activists are demanding an international treaty on medical research and development (R&D) to speed up the creation of cheap medicines.

Outdated intellectual property (IP) regimes and market distortions hold back research on new medicines, activists said at a meeting of the UN Secretary-General’s High-Level Panel on Access to Medicines, held on 10 March in London, United Kingdom.

“We do our R&D in an IP system that has created a hugely wasteful process,” said Els Torreele, the director of the Access to Essential Medicines Initiative of grant-making network the Open Society Foundations. “We could do so much better if we weren’t limiting ourselves to only innovating what we can also patent.”

Read the full article in SciDev.net